Cargando…

Overexpression of Cyclooxygenase-2 and Transforming Growth Factor-Beta 1 is an Independent Predictor of Poor Virological Response to Interferon Therapy in Chronic HCV Genotype 4 Patients

BACKGROUND/AIMS: COX-2 and TGF-β1 are overexpressed in hepatitis C virus (HCV) infection and are related to hepatitis pathogenesis and hepatic fibrosis. The current study investigated the relationship between pretreatment COX-2 and TGF-β1 hepatic expression in HCV genotype 4 and the virological resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomaa, Wafaey M., Ibrahim, Mohammed A., Shatat, Mohamed E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952423/ https://www.ncbi.nlm.nih.gov/pubmed/24496160 http://dx.doi.org/10.4103/1319-3767.126324

Ejemplares similares

Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response
por: Etoh, Reiko, et al.
Publicado: (2011)

ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection
por: Asselah, Tarik, et al.
Publicado: (2015)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C
por: Estrabaud, Emilie, et al.
Publicado: (2015)

Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
por: Feng, Bo, et al.
Publicado: (2014)

Intravenous drug use – an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients
por: Salemovic, Dubravka, et al.
Publicado: (2017)

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
por: Niederau, Claus, et al.
Publicado: (2014)

Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis
por: Ahmed, Mohammed Mahmound, et al.
Publicado: (2013)

Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis
por: Al-Maghrabi, Basim, et al.
Publicado: (2019)

Host genetic variations are associated with virological response to interferon therapy of chronic HCV in Han Chinese patients
por: Chen, Hongbo, et al.
Publicado: (2014)

Loss of Villin Immunoexpression in Colorectal Carcinoma Is Associated with Poor Differentiation and Survival
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2013)

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV
por: Odolini, Silvia, et al.
Publicado: (2014)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
por: Orr, Cody, et al.
Publicado: (2020)

Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
por: Coppola, Nicola, et al.
Publicado: (2014)

Genotype-independent plant transformation
por: Maren, Nathan A, et al.
Publicado: (2022)

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
por: Muazzam, Ambreen G, et al.
Publicado: (2011)

Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections
por: Manickam, Cordelia, et al.
Publicado: (2014)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019)

Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4
por: Shaker, Olfat, et al.
Publicado: (2013)

Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment
por: Zhang, Geng-lin, et al.
Publicado: (2017)

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4
por: Kozielewicz, Dorota, et al.
Publicado: (2018)

High COX-2 immunostaining in papillary thyroid carcinoma is associated with adverse survival outcomes
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2022)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis
por: Khairy, Marwa, et al.
Publicado: (2013)

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients
por: Huang, Chung-Feng, et al.
Publicado: (2013)

HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b
por: Fan, Zhijuan, et al.
Publicado: (2019)

Molecular Virology of Hepatitis C Virus (HCV): 2006 Update
por: Brass, Volker, et al.
Publicado: (2006)

Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients
por: Marchetti, Giulia, et al.
Publicado: (2012)

The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin
por: Szymanek-Pasternak, Anna, et al.
Publicado: (2016)

A Case Report of Thyroid Plasmacytoma and Literature Update
por: Refai, Fahd, et al.
Publicado: (2019)

The Relationship between Virological Characteristics of Hepatitis C Virus (HCV) and Reactivity to the Regional Specific Proteins of HCV(*)
por: Yoon, Seung Kew, et al.
Publicado: (2000)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study
por: Borba, Helena HL, et al.
Publicado: (2017)

Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects
por: Abdo, Ayman A., et al.
Publicado: (2009)

Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2016)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Cyclooxygenase-2 overexpression abrogates the antiproliferative effects of TGF-β
por: Enders, G A
Publicado: (2007)

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
por: Smit, Colette, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bgke52mvkjlf45m0p421hep2es